PTPRC and melanoma: After enrichment, CTCs were stained for either pan-keratins for breast cancer and NSCLC or PMEL17/Melan-A for melanoma samples, DAPI for nuclear identification and for the leucocyte exclusion marker CD45 (Supplementary Figure S1).